Transient Ischemic Attack : A Statement for Healthcare Professionals From the Guidelines for Prevention of Stroke in Patients With Ischemic Stroke
暂无分享,去创建一个
K. Furie | J. Halperin | R. Adams | P. Gorelick | L. Schwamm | M. Kelly-Hayes | S. Johnston | L. Goldstein | G. Albers | M. Marks | M. Alberts | O. Benavente | I. Katzan | E. Kenton | Thomas Tomsick | Harbaugh | M. Kelly‐Hayes | Harbaugh | Ralph L. Sacco | Robert Harbaugh | Robert Harbaugh | R. L. Sacco
[1] J R Hughes,et al. Antidepressants for smoking cessation. , 2014, The Cochrane database of systematic reviews.
[2] P. Touboul,et al. Stroke prevention, blood cholesterol and statins. , 2005, Acta neurologica Taiwanica.
[3] J. Piette,et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome , 2005, Annals of the rheumatic diseases.
[4] S. Kasner,et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. , 2005, The New England journal of medicine.
[5] P. Rothwell,et al. Timing of TIAs preceding stroke , 2005, Neurology.
[6] A. Bld. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis , 2005 .
[7] J. Saver,et al. Expanding indications for statins in cerebral ischemia: a quantitative study. , 2005, Archives of neurology.
[8] A. Tapaninaho. Deep vein thrombosis after aneurysm surgery , 2005, Acta Neurochirurgica.
[9] S. Windecker,et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. , 2018, Neurology.
[10] Iva Petkovska,et al. Virtual TeleStroke support for the emergency department evaluation of acute stroke. , 2004, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[11] A. Hingorani,et al. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. , 2004, Archives of neurology.
[12] S. Kjeldsen,et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The value randomised trial☆ , 2004 .
[13] S. Pauker,et al. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[14] Giancarlo Agnelli,et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[15] A. Greinacher,et al. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[16] J. Hirsh,et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[17] Lippincott Williams Wilkins,et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .
[18] M. Monreal,et al. Fixed‐dose low‐molecular‐weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study , 2004, Journal of thrombosis and haemostasis : JTH.
[19] H. Diener,et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.
[20] Anticoagulants for Preventing Stroke in Patients With Nonrheumatic Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack , 2004, The Cochrane database of systematic reviews.
[21] P A Poole-Wilson,et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. , 2004, American heart journal.
[22] J. Laragh,et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial , 2004, The Lancet.
[23] A. Tonkin,et al. Statins for stroke prevention: disappointment and hope. , 2004, Circulation.
[24] P. Lapuerta,et al. Non-adherence to antipsychotic medication regimens: Associations with resource use and costs , 2004, British Journal of Psychiatry.
[25] J. Bogousslavsky,et al. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus , 2004, Neurology.
[26] David Sacks,et al. Reporting Standards for Carotid Artery Angioplasty and Stent Placement , 2004, Journal of vascular and interventional radiology : JVIR.
[27] S. Lewis. Statin therapy in the elderly: observational and randomized controlled trials support event reduction. , 2004, The American journal of geriatric cardiology.
[28] D. Torres-Russotto,et al. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. , 2004, Journal of vascular surgery.
[29] R. Gliklich,et al. Get with the guidelines for cardiovascular secondary prevention: pilot results. , 2004, Archives of internal medicine.
[30] Satoshi Sasaki,et al. Alcohol Consumption and Risk of Stroke Among Middle-Aged Men: The JPHC Study Cohort I , 2004, Stroke.
[31] Ssylvia Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study Results , 2004, Stroke.
[32] John Robbins,et al. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.
[33] S. Kasner,et al. Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: Report of the Quality Standards Subcommittee of the American Academy of Neurology* , 2004, Neurology.
[34] C. O'connor,et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. , 2004, Journal of cardiac failure.
[35] A. Logan,et al. Acute candesartan cilexetil therapy in stroke survivors. , 2004, Current hypertension reports.
[36] F. Zanella,et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents--initial experience. , 2004, Radiology.
[37] K. Jamerson,et al. The Disproportionate Impact of Hypertensive Cardiovascular Disease in African Americans: Getting to the Heart of the Issue , 2004, Journal of clinical hypertension.
[38] M. Eliasziw,et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery , 2004, The Lancet.
[39] D. Levy,et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. , 2004, The American journal of cardiology.
[40] R. Collins,et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.
[41] Anthony Rodgers,et al. Blood Pressure and Stroke: An Overview of Published Reviews , 2004, Stroke.
[42] D. Corella,et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke , 2004, Thrombosis and Haemostasis.
[43] R. Sacco,et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. , 2004, JAMA.
[44] L. Chambless,et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. , 2004, JAMA.
[45] S. Engelter,et al. Antithrombotic Drugs for Carotid Artery Dissection , 2004 .
[46] Todd H Wagner,et al. Problems paying out-of-pocket medication costs among older adults with diabetes. , 2004, Diabetes care.
[47] Deepak L. Bhatt,et al. Benefit of Clopidogrel Over Aspirin Is Amplified in Patients With a History of Ischemic Events , 2004, Stroke.
[48] A. Folsom,et al. Alcohol Intake and Cerebral Abnormalities on Magnetic Resonance Imaging in a Community-Based Population of Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study , 2003, Stroke.
[49] H. Herrmann. Protected Carotid Stenting vs. Endarterectomy in High-Risk Patients , 2004 .
[50] R. Higashida,et al. Reporting standards for carotid artery angioplasty and stent placement. , 2004, Stroke.
[51] S. Grundy,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[52] K. Ataga,et al. Hypercoagulability in sickle cell disease: a curious paradox. , 2003, The American journal of medicine.
[53] David Z. Wang. Editorial comment-- telemedicine: the solution to provide rural stroke coverage and the answer to the shortage of stroke neurologists and radiologists. , 2003, Stroke.
[54] R. Becker,et al. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. , 2003, American heart journal.
[55] M. Gomori,et al. Emergent Stenting to Treat Patients With Carotid Artery Dissection: Clinically and Radiologically Directed Therapeutic Decision Making , 2003, Stroke.
[56] B. Widder,et al. Teleneurology to Improve Stroke Care in Rural Areas: The Telemedicine in Stroke in Swabia (TESS) Project , 2003, Stroke.
[57] A. Woolfenden,et al. Cervical Arterial Dissection: Time for a Therapeutic Trial? , 2003, Stroke.
[58] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[59] J. Gauvrit,et al. Risk of stroke and recurrent dissection after a cervical artery dissection , 2003, Neurology.
[60] Paul Khairy,et al. Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli , 2003, Annals of Internal Medicine.
[61] M. Endres,et al. Mechanisms of stroke protection by physical activity , 2003, Annals of neurology.
[62] L. Lisabeth,et al. Access to Care, Acculturation, and Risk Factors for Stroke in Mexican Americans: The Brain Attack Surveillance in Corpus Christi (BASIC) Project , 2003, Stroke.
[63] J. Leonardi-Bee,et al. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review , 2003, Stroke.
[64] B. Hoogwerf,et al. The Heart Protection Study: high-risk patients benefit from statins, regardless of LDL-C level. , 2003, Cleveland Clinic journal of medicine.
[65] A. Mokdad,et al. Trends in waist circumference among U.S. adults. , 2003, Obesity research.
[66] E. Ringelstein,et al. Cervical artery dissection—clinical features, risk factors, therapy and outcome in 126 patients , 2003, Journal of Neurology.
[67] David C. Hess,et al. Remote Evaluation of Acute Ischemic Stroke: Reliability of National Institutes of Health Stroke Scale via Telestroke , 2003, Stroke.
[68] Ka Sing Wong,et al. Cerebral Microbleeds as a Risk Factor for Subsequent Intracerebral Hemorrhages Among Patients With Acute Ischemic Stroke , 2003, Stroke.
[69] A. Arauz,et al. Prospective Study of Single and Multiple Lacunar Infarcts Using Magnetic Resonance Imaging: Risk Factors, Recurrence, and Outcome in 175 Consecutive Cases , 2003, Stroke.
[70] J. Douketis,et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. , 2003, The New England journal of medicine.
[71] J. Halperin,et al. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). , 2003, American heart journal.
[72] M. Hennerici,et al. Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study , 2003, Cerebrovascular Diseases.
[73] S. Studenski,et al. Randomized clinical trial of therapeutic exercise in subacute stroke. , 2003, Stroke.
[74] R. Sacco,et al. Race-ethnic differences in patent foramen ovale, atrial septal aneurysm, and right atrial anatomy among ischemic stroke patients. , 2003, Stroke.
[75] N. Feldstein,et al. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure. , 2003, Pediatric neurology.
[76] P. Ridker,et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism☆ , 2003 .
[77] Ralph L. Sacco,et al. Abdominal Obesity and Risk of Ischemic Stroke: The Northern Manhattan Stroke Study , 2003, Stroke.
[78] D. Singer,et al. Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis , 2003, Stroke.
[79] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[80] S. Leurgans,et al. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. , 2003, JAMA.
[81] C. Wolfe,et al. Cause of Stroke Recurrence Is Multifactorial: Patterns, Risk Factors, and Outcomes of Stroke Recurrence in the South London Stroke Register , 2003, Stroke.
[82] G. Albers,et al. Spinal manipulative therapy is an independent risk factor for vertebral artery dissection , 2003, Neurology.
[83] P. Bassi,et al. Cervical cerebral artery dissection: a multicenter prospective study (preliminary report) , 2003, Neurological Sciences.
[84] A. Folsom,et al. Physical Activity and Stroke Risk: A Meta-Analysis , 2003, Stroke.
[85] P. Ridker,et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.
[86] R. Grubb,et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association , 2003, Stroke.
[87] K. Miura,et al. High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study , 2003, Stroke.
[88] C. Wolfe,et al. Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After Stroke: Data From the European BIOMED Stroke Project , 2003, Stroke.
[89] P. Hu,et al. Telemedicine for Acute Stroke: Triumphs and Pitfalls , 2003, Stroke.
[90] K. Reynolds,et al. Alcohol consumption and risk of stroke: a meta-analysis. , 2003, JAMA.
[91] M. Borrego,et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? , 2003, International journal of cardiology.
[92] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[93] D. Allison,et al. Years of life lost due to obesity. , 2003, JAMA.
[94] L. Vignolo,et al. Inherited Thrombophilic Disorders in Young Adults With Ischemic Stroke and Patent Foramen Ovale , 2003, Stroke.
[95] S. Jencks,et al. Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. , 2003, JAMA.
[96] J. Serena,et al. [Patent foramen ovale and cryptogenic stroke: where to go from here]. , 2003, Revista espanola de cardiologia.
[97] K. Johnston,et al. Teleradiology Assessment of Computerized Tomographs Online Reliability Study (TRACTORS) for acute stroke evaluation. , 2003, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[98] R. Klein,et al. Implications of the United kingdom prospective diabetes study. , 2003, Diabetes care.
[99] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[100] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Journal of the American College of Cardiology.
[101] Nancy R Cook,et al. Body mass index and the risk of stroke in men. , 2002, Archives of internal medicine.
[102] J. Mohr,et al. Transient ischemic attack--proposal for a new definition. , 2002, The New England journal of medicine.
[103] D. Pella,et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial , 2002, The Lancet.
[104] V. Fairbanks,et al. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA) , 2002, American journal of hematology.
[105] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.
[106] M. MacKay-Lyons,et al. Cardiovascular stress during a contemporary stroke rehabilitation program: is the intensity adequate to induce a training effect? , 2002, Archives of physical medicine and rehabilitation.
[107] Carl J Pepine,et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.
[108] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[109] H. Arnesen,et al. Warfarin, aspirin, or both after myocardial infarction. , 2002, The New England journal of medicine.
[110] Deepak L. Bhatt,et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. , 2002, The American journal of cardiology.
[111] Roger B. Davis,et al. Obesity among adults with disabling conditions. , 2002, JAMA.
[112] E. Rothenberg,et al. Waist Circumference, Body Mass Index, and Risk for Stroke in Older People , 2002, Journal of the American Geriatrics Society.
[113] K. Christensen,et al. Cessation of Smoking After First-Ever Stroke: A Follow-Up Study , 2002, Stroke.
[114] M L Simoons,et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). , 2002, European heart journal.
[115] W Klein,et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). , 2002, European heart journal.
[116] Eric E. Smith,et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke , 2002, Neurology.
[117] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[118] James F Sallis,et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.
[119] D. Grobbee,et al. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial , 2002, The Lancet.
[120] B. Nordestgaard,et al. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. , 2002, Blood.
[121] R. Sacco,et al. Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study , 2002, Circulation.
[122] S. Grundy,et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association , 2002, Circulation.
[123] J. Fleg,et al. Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention , 2002, Circulation.
[124] R. D'Agostino,et al. Alcohol Consumption and Risk of Ischemic Stroke: The Framingham Study , 2002, Stroke.
[125] C. Wongvipaporn,et al. A prognostic model for predicting the disappearance of left atrial thrombi among candidates for percutaneous transvenous mitral commissurotomy. , 2002, Journal of the American College of Cardiology.
[126] C. Viscoli,et al. A clinical trial of estrogen-replacement therapy after ischemic stroke , 2002 .
[127] J. Borg,et al. Antiphospholipid Antibodies in the Acute Phase of Cerebral Ischaemia in Young Adults: A Descriptive Study of 139 Patients , 2002, Cerebrovascular Diseases.
[128] P. Mehler,et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. , 2002, Kidney international.
[129] P. Gorelick. Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review , 2002, Stroke.
[130] R. Ceratto,et al. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. , 2002, AJNR. American journal of neuroradiology.
[131] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[132] G. Di Minno,et al. Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke , 2002, Stroke.
[133] J. Coste,et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. , 2002, Stroke.
[134] Diane K Wagener,et al. Trends in racial and ethnic-specific rates for the health status indicators: United States, 1990-98. , 2002, Healthy People 2000 statistical notes.
[135] J. Coste,et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.
[136] D. Altmann,et al. Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic review. , 2001, Addiction.
[137] K. Sullivan,et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[138] U. de Faire,et al. Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures: A HOPE Substudy , 2001, Hypertension.
[139] J. Cox,et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. , 2001, BMJ : British Medical Journal.
[140] K. Furie,et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.
[141] S. Graham. To anticoagulate or not to anticoagulate patients with cardiomyopathy. , 2001, Cardiology clinics.
[142] E. Deshaies,et al. Critical care of intracerebral and subarachnoid hemorrhage , 2001, Current neurology and neuroscience reports.
[143] J. Anderson,et al. Obesity and disease management: effects of weight loss on comorbid conditions. , 2001, Obesity research.
[144] V. Fuster,et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.
[145] V F Froelicher,et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. , 2001, Circulation.
[146] H. Kwiecinski,et al. Factor V Leiden, Prothrombin Gene G20210A Variant, and Methylenetetrahydrofolate Reductase C677T Genotype in Young Adults With Ischemic Stroke , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[147] G. Albers,et al. Potential utility of diffusion-weighted imaging in venous infarction. , 2001, Archives of neurology.
[148] D. Johnston. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.
[149] V. Fuster,et al. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. , 2001, Circulation.
[150] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[151] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[152] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[153] G. Friedman,et al. Alcohol drinking and risk of hospitalization for ischemic stroke. , 2001, The American journal of cardiology.
[154] J. Jenkins,et al. Vertebral artery stenting , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[155] A. Kakkar,et al. Thromboprophylaxis in the Cancer Patient , 2001, Acta Haematologica.
[156] D. Siscovick,et al. Alcohol Consumption and Subclinical Findings on Magnetic Resonance Imaging of the Brain in Older Adults: The Cardiovascular Health Study , 2001, Stroke.
[157] S. Yusuf,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.
[158] G. Hankey,et al. Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes , 2001, Stroke.
[159] Steven Shea,et al. Race-Ethnic Disparities in the Impact of Stroke Risk Factors: The Northern Manhattan Stroke Study , 2001, Stroke.
[160] R H Myers,et al. Genetic and Environmental Contributions to Platelet Aggregation: The Framingham Heart Study , 2001, Circulation.
[161] L. Brass,et al. Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) , 2001, Circulation.
[162] J M Bland,et al. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial , 2001, The Lancet.
[163] W. Hacke,et al. Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.
[164] P. Sandercock. Statins for stroke prevention? , 2001, The Lancet.
[165] H. Diener,et al. CARDIAC SAFETY IN THE EUROPEAN STROKE PREVENTION STUDY 2 (ESPS2) , 2001, International journal of clinical practice.
[166] J. Hsia,et al. Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS) , 2001, Circulation.
[167] S. Borzak,et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? , 2001, Chest.
[168] M. Alberts,et al. Results of a Multicenter Prospective Randomized Trial of Carotid Artery Stenting vs. Carotid Endarterectomy , 2001, Stroke.
[169] C. Wolfe,et al. Cerebrovascular Risk Factors and Stroke Subtypes: Differences Between Ethnic Groups , 2001, Stroke.
[170] Richard F. Macko,et al. Alcohol Intake, Type of Beverage, and the Risk of Cerebral Infarction in Young Women , 2001, Stroke.
[171] Azar,et al. A COMPARISON OF WARFARIN AND ASPIRIN FOR THE PREVENTION OF RECURRENT ISCHEMIC STROKE , 2001 .
[172] D. Mant,et al. Nicotine replacement therapy for smoking cessation. , 2004, The Cochrane database of systematic reviews.
[173] P A Wolf,et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. , 2001, Circulation.
[174] S. Sidney,et al. Short-term prognosis after emergency department diagnosis of TIA. , 2000, JAMA.
[175] E. Wijdicks,et al. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. , 2000, Archives of neurology.
[176] W. Rogers,et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.
[177] K. McPherson,et al. Modelling the short term consequences of smoking cessation in England on the hospitalisation rates for acute myocardial infarction and stroke , 2000, Tobacco control.
[178] R J Shephard,et al. The economic burden of physical inactivity in Canada. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[179] J W Erdman,et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. , 2000, Stroke.
[180] S. Engelter,et al. Long-Term Follow-Up after Extracranial Internal Carotid Artery Dissection , 2000, European Neurology.
[181] J. Gaspoz,et al. Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack. , 2000, Archives of internal medicine.
[182] F. Fedele,et al. Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications , 2000, Stroke.
[183] W. Schievink. The treatment of spontaneous carotid and vertebral artery dissections. , 2000, Current opinion in cardiology.
[184] T. van der Poll,et al. Novel approaches to the management of disseminated intravascular coagulation , 2000, Critical care medicine.
[185] G. Albers,et al. Symptomatic intracranial atherosclerosis , 2000, Neurology.
[186] John S Yudkin,et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.
[187] E. Fracassi,et al. Waist circumference and abdominal sagittal diameter as surrogates of body fat distribution in the elderly: their relation with cardiovascular risk factors , 2000, International Journal of Obesity.
[188] Thomas Hedner,et al. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.
[189] W R Bell,et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. , 2000, The New England journal of medicine.
[190] G A Colditz,et al. Physical activity and risk of stroke in women. , 2000, JAMA.
[191] Patricia Dolan Mullen,et al. Treating tobacco use and dependence: clinical practice guideline , 2000 .
[192] A M Malek,et al. Endovascular management of extracranial carotid artery dissection achieved using stent angioplasty. , 2000, AJNR. American journal of neuroradiology.
[193] T. Neumann-Haefelin,et al. Surgical treatment of 50 carotid dissections: indications and results. , 2000, Journal of vascular surgery.
[194] D. Rüfenacht,et al. Percutaneous transluminal angioplasty and stenting of the proximal vertebral artery for symptomatic stenosis. , 2000, AJNR. American journal of neuroradiology.
[195] W. Hacke,et al. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation , 2000, Journal of Neurology.
[196] T. Pearson,et al. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. , 2000, Archives of internal medicine.
[197] B. Damasceno,et al. Inherited Thrombophilia as a Risk Factor for the Development of Ischemic Stroke in Young Adults , 2000, Thrombosis and Haemostasis.
[198] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[199] E. Nussbaum,et al. Extracranial-intracranial bypass for ischemic cerebrovascular disease refractory to maximal medical therapy. , 2000, Neurosurgery.
[200] P. Rothwell,et al. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. , 2000, Stroke.
[201] A. Pancioli,et al. Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. , 1999, Stroke.
[202] J. Buring,et al. Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians. , 1999, The New England journal of medicine.
[203] C. Mullany,et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. , 1999, Circulation.
[204] R. Ware,et al. Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children With Sickle Cell Disease , 1999 .
[205] R. Sacco,et al. Supplement to the Guidelines for the Management of Transient Ischemic Attacks A Statement From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association , 1999 .
[206] L Bozzao,et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.
[207] S. Juvela,et al. Recent heavy drinking of alcohol and embolic stroke. , 1999, Stroke.
[208] J. Alpert,et al. ACC/AHA guidelines for coronary artery bypass graft surgery , 1999 .
[209] P. Williamson,et al. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. , 1999, The Journal of laboratory and clinical medicine.
[210] J. Gorter,et al. Major bleeding during anticoagulation after cerebral ischemia , 1999, Neurology.
[211] J. Terry,et al. Extracranial vertebral artery stent placement: in-hospital and follow-up results. , 1999, Journal of neurosurgery.
[212] J. Kvedar,et al. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. , 1999, Stroke.
[213] A M Malek,et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. , 1999, Stroke.
[214] S. Grundy,et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.
[215] J. Connors,et al. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. , 1999, Journal of neurosurgery.
[216] P A Wolf,et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. , 1999, Stroke.
[217] J. Tuomilehto,et al. Diabetes and Glucose Intolerance as Risk Factors for Stroke , 1999, Journal of cardiovascular risk.
[218] L. Brunereau,et al. Long-term follow-up of aneurysms developed during extracranial internal carotid artery dissection , 1999, Neurology.
[219] M. Margaglione,et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[220] T. Truelsen,et al. Passive smoking as well as active smoking increases the risk of acute stroke , 1999, Tobacco control.
[221] T. Mori,et al. Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. , 1999, AJNR. American journal of neuroradiology.
[222] J. McNeil,et al. Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. , 1999, American journal of public health.
[223] J M Zabramski,et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1999, Stroke.
[224] P. Whelton,et al. Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.
[225] P. Ridker,et al. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. , 1999, Circulation.
[226] T. Rychlewski,et al. The influence of short-term endurance training on the insulin blood level, binding, and degradation of 125I-insulin by erythrocyte receptors in patients after myocardial infarction. , 1999, Journal of cardiopulmonary rehabilitation.
[227] H. Büller,et al. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. , 1999, Stroke.
[228] C. McDougall,et al. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. , 1999, Stroke.
[229] R. Feldman,et al. The Three Leading Causes of Death in African Americans: Barriers to Reducing Excess Disparity and to Improving Health Behaviors , 1999, Journal of health care for the poor and underserved.
[230] A. Fox,et al. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trail. , 1999, Stroke.
[231] J. Manson,et al. Exercise and risk of stroke in male physicians. , 1996, Stroke.
[232] R. Jeresaty. Mitral Valve Prolapse , 1974, The New England journal of medicine.
[233] B. Cujec,et al. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. , 1999, The Canadian journal of cardiology.
[234] C. Bulpitt,et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. , 1999, The New England journal of medicine.
[235] M. B. Lewis,et al. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? , 1999, Stroke.
[236] R. Sacco,et al. The protective effect of moderate alcohol consumption on ischemic stroke. , 1999, JAMA.
[237] T. Mori,et al. Follow-up Study after Intracranial Percutaneous Transluminal Cerebral Balloon Angioplasty , 2000, AJNR. American journal of neuroradiology.
[238] W J Powers,et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. , 1999, JAMA.
[239] R. Gillum,et al. Stroke in Blacks: A Guide to Management and Prevention , 1998 .
[240] B. Davis,et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.
[241] Tait,et al. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2‐year follow‐up , 1998, British journal of haematology.
[242] P. Gorelick. Cerebrovascular disease in African Americans. , 1998, Stroke.
[243] L. Tatu,et al. Stroke patterns of internal carotid artery dissection in 40 patients. , 1998, Stroke.
[244] D. Sackett,et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.
[245] E. Antman,et al. Guidelines for the management of patients with valvular heart disease: executive summary , 1998, Circulation.
[246] M. Telfer,et al. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. , 1998, Blood.
[247] F. Kirkham,et al. Inherited prothrombotic states and ischaemic stroke in childhood , 1998, Journal of neurology, neurosurgery, and psychiatry.
[248] S Hulley,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[249] P R Bell,et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. , 1998, Journal of vascular surgery.
[250] Scott T. Miller,et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.
[251] H. Winn,et al. Management of the ruptured aneurysm. , 1998, Neurosurgery clinics of North America.
[252] M. Ezekowitz. Antithrombotics for left-ventricular impairment? , 1998, The Lancet.
[253] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[254] C. Klonaris,et al. Surgical treatment of spontaneous internal carotid dissection. , 1998, International angiology : a journal of the International Union of Angiology.
[255] P. Chiusolo,et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. , 1998, Blood.
[256] R. Sacco,et al. Cigarette smoking as a determinant of high-grade carotid artery stenosis in Hispanic, black, and white patients with stroke or transient ischemic attack. , 1998, Stroke.
[257] R. Sacco,et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. , 1998, Stroke.
[258] M. Pahor,et al. Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM , 1998, Diabetes Care.
[259] R. Schrier,et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. , 1998, The New England journal of medicine.
[260] T. Raghunathan,et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) , 1998, Stroke.
[261] R. Sacco,et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. , 1998, Stroke.
[262] W. O'Fallon,et al. Survival and recurrence after first cerebral infarction , 1998, Neurology.
[263] D. Han,et al. Clinical characteristics of vertebrobasilar artery dissection. , 1998, Neurologia medico-chirurgica.
[264] R. Gibbons,et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). , 1998, The Journal of heart valve disease.
[265] G. Agnelli,et al. Antithrombotic therapy for venous thromboembolic disease. , 1998, Chest.
[266] W. Jordan,et al. A comparison of carotid angioplasty with stenting versus endarterectomy with regional anesthesia. , 1998, Journal of vascular surgery.
[267] Scott T. Miller,et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.
[268] R. Sacco,et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. , 1997, Stroke.
[269] F. Verheugt,et al. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin , 1997, Annals of neurology.
[270] I. Martinelli,et al. The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with cerebral ischemia. , 1997, Blood.
[271] S. Levine,et al. IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. , 1997, Stroke.
[272] S. Glantz,et al. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. , 1997, Circulation.
[273] R N Bryan,et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of the Stroke Council, American Heart Association. , 1997, Stroke.
[274] J. Manson,et al. A prospective study of body mass index, weight change, and risk of stroke in women. , 1997, JAMA.
[275] J. Bogousslavsky,et al. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism. Early results of a preliminary study. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[276] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[277] W. Heiss,et al. MRI- and MRA-guided therapy of carotid and vertebral artery dissections , 1997, Journal of the Neurological Sciences.
[278] L. Breimer,et al. Fibrinogen as a cardiovascular risk factor. , 1997, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[279] M. Evans,et al. Body weight and mortality among women. , 1997, Canadian family physician Medecin de famille canadien.
[280] M. Hill,et al. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. , 1997, Circulation.
[281] E. Vichinsky,et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. , 1997, The American journal of medicine.
[282] G. Lamas,et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.
[283] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[284] E. Rimm,et al. Body size and fat distribution as predictors of stroke among US men. , 1996, American journal of epidemiology.
[285] M. Dennis. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .
[286] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[287] H. Diener,et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.
[288] P. Despland,et al. Prognosis after stroke followed by surgical closure of patent foramen ovale , 1996, Neurology.
[289] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[290] D. Cossman,et al. Spontaneous dissection of the internal carotid artery: a nineteen-year clinical experience. , 1996, Journal of vascular surgery.
[291] C. Bassetti,et al. Recurrence of cervical artery dissection. A prospective study of 81 patients. , 1996, Stroke.
[292] D. Abendschein,et al. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[293] R. Macko,et al. Pregnancy and the risk of stroke , 1996, The New England journal of medicine.
[294] W. J. Hamilton,et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.
[295] D. Singer,et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.
[296] J. Slattery,et al. Blood pressure and risk of stroke in patients with cerebrovascular disease , 1996, BMJ.
[297] S. Wannamethee,et al. Patterns of alcohol intake and risk of stroke in middle-aged British men. , 1996, Stroke.
[298] M. Eberhardt,et al. Report of the AAN Task Force on access to health care , 1996, Neurology.
[299] M. Dake,et al. Vertebral artery stenting following percutaneous transluminal angioplasty. Technical note. , 1996, Journal of neurosurgery.
[300] J. Bogousslavsky,et al. Stroke recurrence in patients with patent foramen ovale , 1996, Neurology.
[301] S. Yusuf,et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. , 1996, The American journal of cardiology.
[302] G. Raskob,et al. Aging and heparin-related bleeding. , 1996, Archives of internal medicine.
[303] N. Pellegrini,et al. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. , 1996, European journal of clinical nutrition.
[304] D. Reda,et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. , 1995, The New England journal of medicine.
[305] S. Ebrahim,et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men , 1995, The Lancet.
[306] J. McGill,et al. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. , 1995, The American journal of medicine.
[307] M. Zuber,et al. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. , 1995, American heart journal.
[308] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[309] R. Hall,et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. , 1995, European heart journal.
[310] S. Wannamethee,et al. Smoking cessation and the risk of stroke in middle-aged men. , 1995, JAMA.
[311] S. Levine,et al. Recurrent stroke and thrombo‐occlusive events in the antiphospholipid syndrome , 1995, Annals of neurology.
[312] Scott T. Miller,et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. , 1995, The Journal of pediatrics.
[313] A. Tverdal,et al. Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women. , 1995, Journal of epidemiology and community health.
[314] P. Prandoni,et al. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. , 1995, Stroke.
[315] A. Myers,et al. Inhibition of platelet aggregation in whole blood by alcohol. , 1995, Thrombosis research.
[316] P. Ridker,et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.
[317] V. Hachinski,et al. The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. , 1995, Archives of neurology.
[318] K. Patrick,et al. Physical Activity and Public Health: A Recommendation From the Centers for Disease Control and Prevention and the American College of Sports Medicine , 1995 .
[319] 康生 大久保,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study , 1995 .
[320] R. Sacco,et al. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. , 1995, Stroke.
[321] K. Yano,et al. Body Mass Index and Thromboembolic Stroke in Nonsmoking Men in Older Middle Age: The Honolulu Heart Program , 1994, Stroke.
[322] J. Batlle,et al. Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects , 1994, Thrombosis and Haemostasis.
[323] H. Tohgi,et al. The anticardiolipin antibody in elderly stroke patients: its effects on stroke types, recurrence, and the coagulation‐fibrinolysis system , 1994, Acta neurologica Scandinavica.
[324] G. Leinsinger,et al. Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass surgery in patients with ICA occlusion and hemodynamic cerebral ischemia. , 1994, Journal of neurosurgery.
[325] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[326] K. Yano,et al. Glucose Intolerance and 22‐Year Stroke Incidence: The Honolulu Heart Program , 1994, Stroke.
[327] B. Lindblad,et al. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C , 1994, The Lancet.
[328] R. Sacco,et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community , 1994, Neurology.
[329] S. Satterfield,et al. Cigarette Smoking and Stroke in a Cohort of U.S. Male Physicians , 1994, Annals of Internal Medicine.
[330] R. Sacco,et al. Characteristics of Patent Foramen Ovale Associated With Cryptogenic Stroke: A Biplane Transesophageal Echocardiographic Study , 1994, Stroke.
[331] B. Dahlbäck,et al. Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.
[332] W. Halbmayer,et al. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[333] C. Anderson,et al. The Role of Lifestyle Factors in the Etiology of Stroke: A Population‐Based Case‐Control Study in Perth, Western Australia , 1994, Stroke.
[334] W. Thies,et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.
[335] G. Rosner,et al. Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study. , 1994, American journal of public health.
[337] F. Rosendaal,et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.
[338] W. Willett,et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. , 1993, The New England journal of medicine.
[339] H. S. Struijker Boudier,et al. Short- and long-term effects of smoking on arterial wall properties in habitual smokers. , 1993, Journal of the American College of Cardiology.
[340] F. Chédru,et al. Atrial Septal Aneurysm and Patent Foramen Ovale as Risk Factors for Cryptogenic Stroke in Patients Less Than 55 Years of Age: A Study Using Transesophageal Echocardiography , 1993, Stroke.
[341] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[342] R. Brey. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke , 1993, Neurology.
[343] S. Endo,et al. A pathological study of intracranial posterior circulation dissecting aneurysms with subarachnoid hemorrhage: report of three autopsied cases and review of the literature. , 1993, Neurosurgery.
[344] G. Boysen,et al. Lifestyle Factors and Risk of Cerebrovascular Disease in Women: The Copenhagen City Heart Study , 1993, Stroke.
[345] P. Khoury,et al. Relation of Left Ventricular Mass, Preload, Afterload and Contractility in Pediatric Patients with Essential Hypertension , 1993, Journal of the American College of Cardiology.
[346] A. Laupacis,et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. , 1993, The New England journal of medicine.
[347] P. Reichard,et al. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.
[348] M. Pessin,et al. Safety of anticoagulation after hemorrhagic infarction , 1993, Neurology.
[349] M. Staten,et al. Insulin Resistance in Aging Is Related to Abdominal Obesity , 1993, Diabetes.
[350] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[351] B Rosner,et al. Smoking cessation and decreased risk of stroke in women. , 1993, JAMA.
[352] M. Brant-Zawadzki,et al. Magnetic Resonance Angiography of Cervicocranial Dissection , 1993, Stroke.
[353] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[354] R. Sacco,et al. Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke , 1992, Annals of Internal Medicine.
[355] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[356] W. Daniel,et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. , 1992, The American journal of cardiology.
[357] W. Willett,et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.
[358] D. Levy,et al. Mitral annular calcification and the risk of stroke in an elderly cohort. , 1992, The New England journal of medicine.
[359] A. Camm,et al. Risk of patent foramen ovale for thromboembolic events in all age groups. , 1992, The American journal of cardiology.
[360] S. Levine,et al. Risk of Recurrent Thromboembolic Events in Patients With Focal Cerebral Ischemia and Antiphospholipid Antibodies , 1992, Stroke.
[361] S. Kittner,et al. Antiphospholipid Antibodies and Stroke: An Epidemiological Perspective , 1992, Stroke.
[362] R. Abbate,et al. Lupus Anticoagulant and Anticardiolipin Antibodies in Young Adults With Cerebral Ischemia , 1992, Stroke.
[363] Ralph G. Dacey,et al. Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis , 1991 .
[364] C Warlow,et al. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[365] J. Manson,et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. , 1991, Archives of internal medicine.
[366] E. Kenton. Access to neurological care for minorities. , 1991, Archives of neurology.
[367] R. Clarke,et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.
[368] Daniel B Hier,et al. Stroke recurrence within 2 years after ischemic infarction. , 1991, Stroke.
[369] T. Jensen,et al. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group , 1991 .
[370] K. M. EinhÃ. Heparin treatment in sinus venous thrombosis. , 1991, Lancet.
[371] R. Falk. A plea for a clinical trial of anticoagulation in dilated cardiomyopathy. , 1990, The American journal of cardiology.
[372] M. Malinow,et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. , 1990, Stroke.
[373] J. Broderick,et al. Ultra-early evaluation of intracerebral hemorrhage. , 1990, Journal of neurosurgery.
[374] H. Adams,et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.
[375] G. Beevers,et al. Meta-analysis of relation between cigarette smoking and stroke. , 1989, BMJ.
[376] Daniel B Hier,et al. Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke , 1989, Neurology.
[377] V. Fuster,et al. Left ventricular thrombi and cerebral embolism. , 1989, The New England journal of medicine.
[378] M. Gent,et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. , 1989, Lancet.
[379] R. Asinger,et al. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. , 1989, Archives of neurology.
[380] W. Willett,et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. , 1988, The New England journal of medicine.
[381] H. J. Smith,et al. PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS , 1988, The Lancet.
[382] R B D'Agostino,et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. , 1988, JAMA.
[383] P. Wolf,et al. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.
[384] I. Schwartz,et al. Calcification of the mitral annulus fibrosus with systemic embolization. A clinicopathologic study of 16 cases. , 1987, Archives of pathology & laboratory medicine.
[385] D. Beevers,et al. Stroke and alcohol consumption. , 1986, The New England journal of medicine.
[386] Denis Roy,et al. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. , 1986, American heart journal.
[387] J. Bogousslavsky,et al. Atherosclerotic disease of the middle cerebral artery. , 1986, Stroke.
[388] C. Mok,et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. , 1985, Circulation.
[389] J. Chiras,et al. Cerebral venous thrombosis--a review of 38 cases. , 1985, Stroke.
[390] M. Mariani,et al. [Systemic embolism in mitral valve disease]. , 1984, Cardiologia.
[391] C. Visser,et al. Long-term follow-up of left ventricular thrombus after acute myocardial infarction. A two-dimensional echocardiographic study in 96 patients. , 1984, Chest.
[392] L. Wilhelmsen,et al. Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.
[393] J. Ross,et al. Mitral annular calcification: clinical, pathophysiology, and echocardiographic review. , 1984, American heart journal.
[394] V. Fuster,et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. , 1983, The American journal of cardiology.
[395] P. Touboul,et al. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. , 1983, Stroke.
[396] M. Clanet,et al. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial]. , 1982, Revue neurologique.
[397] V. Fuster,et al. The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.
[398] R. Adolph,et al. Calcium emboli to the retinal artery in calcific aortic stenosis. , 1981, American heart journal.
[399] P. Kishore,et al. Major intracerebral arterial involvement in sickle cell disease. , 1980, Surgical neurology.
[400] J. Talano,et al. Transient ischemic attack associated with mitral systolic clicks. , 1979, Archives of internal medicine.
[401] B. M. Beaver,et al. Calcification of the mitral annulus: etiology, clinical associations, complications and therapy. , 1979, The American journal of medicine.
[402] W. Kannel,et al. Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.
[403] G. Hirsowitz,et al. Hemiplegia and the billowing mitral leaflet syndrome. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[404] A randomized trial of aspirin and sulfinpyrazone in threatened stroke. , 1978, The New England journal of medicine.
[405] E. Myhre,et al. Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves. , 1977, American heart journal.
[406] J. Pitha,et al. Continuing disease process of calcific aortic stenosis. Role of microthrombi and turbulent flow. , 1977, The American journal of cardiology.
[407] E. Crowell,et al. Randomized prospective trial of continuous vs intermittent heparin therapy. , 1976, JAMA.
[408] Hutchins Gm,et al. Spontaneous calcific emboli from calcific mitral annulus fibrosus. , 1976 .
[409] T. Mochizuki,et al. Effect of athrombogenic therapy, especially high dose therapy of dipyridamole, after prosthetic valve replacement. , 1975, The Journal of cardiovascular surgery.
[410] H. Barnett,et al. Cerebral ischemic events associated with prolapsing mitral valve. , 1975, Transactions of the American Neurological Association.
[411] J. Merrett,et al. Cerebral embolism and mitral stenosis: survival with and without anticoagulants , 1974, Journal of neurology, neurosurgery, and psychiatry.
[412] G. Mann. The influence of obesity on health (second of two parts). , 1974, The New England journal of medicine.
[413] H. Fleming. Anticoagulants in rheumatic heart-disease. , 1971, Lancet.
[414] R. Gorlin,et al. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. , 1971, The New England journal of medicine.
[415] R. S. Kirk,et al. Subvalvular calcification of mitral valve. , 1969, British heart journal.
[416] P. Olley,et al. Incidence of systemic embolism before and after mitral valvotomy. , 1968, Thorax.
[417] C. Fisher,et al. Atherosclerosis of the Carotid and Vertebral Arteries—Extracranial and Intracranial , 1965 .
[418] P. Szekely. Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease , 1964, British medical journal.
[419] R. Bahn,et al. Spontaneous Calcific Embolization Associated with Calcific Aortic Stenosis , 1963, Circulation.
[420] J. Guthrie,et al. CASE REPORTS AORTIC EMBOLISM DUE TO MYXOlD TUMOUR ASSOCIATED WITH MYOCARDIAL CALCIFICATION , 2022 .
[421] R. Desanctis,et al. Massive calcification of the mitral annulus. A clinicopathological study of fourteen cases. , 1962, The New England journal of medicine.
[422] A. B. Carter. Prognosis of Cerebral Embolism , 1958 .
[423] P. Wood,et al. Diseases of the Heart and Circulation , 1904, The Hospital.
[424] C. Friedberg. DISEASES OF THE HEART , 1933, The Ulster Medical Journal.